title: Breast cancer: Increasing therapy options for HER2-positive early breast cancer.
authors.forename: Nadia
authors.initials: N
authors.lastname: Harbeck
mesh_terms: D018943:Anthracyclines / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D001952:Bridged-Ring Compounds / Q000627:therapeutic use; D016190:Carboplatin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D018450:Disease Progression; D000077143:Docetaxel; D005260:Female; D018734:Genes, erbB-2 / Q000235:genetics*; D006801:Humans; D043823:Taxoids / Q000627:therapeutic use; D013997:Time Factors; D000068878:Trastuzumab
chemical_list: D018943:Anthracyclines; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D001952:Bridged-Ring Compounds; D043823:Taxoids; D000077143:Docetaxel; C080625:taxane; D003520:Cyclophosphamide; D016190:Carboplatin; D000068878:Trastuzumab